In vivo imaging in the 21st century is increasingly being performed with significant industrial collaborations between Pharmaceutical companies and academic and healthcare providers. This is a mutually beneficial situation which can enable in vivo imaging in ways previously unimaginable. The Drug Development Interest Group is a springboard for those of you interested in engaging and finding out more about these activities. The field is multidisciplinary in nature, covering a gamut of activities including synthetic and medicinal chemistry, biology, pharmacology, pharmacokinetics/dynamics, clinical sciences, technology and instrumentation, mathematical modelling and physics.